101 related articles for article (PubMed ID: 10985766)
1. Interactions of conformationally biased north and south 2'-fluoro-2', 3'-dideoxynucleoside 5'-triphosphates with the active site of HIV-1 reverse transcriptase.
Mu L; Sarafianos SG; Nicklaus MC; Russ P; Siddiqui MA; Ford H; Mitsuya H; Le R; Kodama E; Meier C; Knispel T; Anderson L; Barchi JJ; Marquez VE
Biochemistry; 2000 Sep; 39(37):11205-15. PubMed ID: 10985766
[TBL] [Abstract][Full Text] [Related]
2. Conformation and local environment of nucleotides bound to HIV type 1 reverse transcriptase (HIV-1 RT) in the ground state.
Painter GR; Andrews CW; Furman PA
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):13-29. PubMed ID: 10772700
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
Periclou AP; Nandy P; Avramis VI
In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of Lys65 of HIV-1 reverse transcriptase.
Sluis-Cremer N; Arion D; Kaushik N; Lim H; Parniak MA
Biochem J; 2000 May; 348 Pt 1(Pt 1):77-82. PubMed ID: 10794716
[TBL] [Abstract][Full Text] [Related]
5. Touching the heart of HIV-1 drug resistance: the fingers close down on the dNTP at the polymerase active site.
Sarafianos SG; Das K; Ding J; Boyer PL; Hughes SH; Arnold E
Chem Biol; 1999 May; 6(5):R137-46. PubMed ID: 10322129
[TBL] [Abstract][Full Text] [Related]
6. Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision.
Boyer PL; Sarafianos SG; Arnold E; Hughes SH
J Virol; 2002 Sep; 76(18):9143-51. PubMed ID: 12186898
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis for the enantioselectivity of HIV-1 reverse transcriptase: role of the 3'-hydroxyl group of the L-(beta)-ribose in chiral discrimination between D- and L-enantiomers of deoxy- and dideoxy-nucleoside triphosphate analogs.
Maga G; Amacker M; Hübscher U; Gosselin G; Imbach JL; Mathé C; Faraj A; Sommadossi JP; Spadari S
Nucleic Acids Res; 1999 Feb; 27(4):972-8. PubMed ID: 9927728
[TBL] [Abstract][Full Text] [Related]
8. Partial selective inhibition of HIV-1 reverse transcriptase and human DNA polymerases γ and β by thiated 3'-fluorothymidine analogue 5'-triphosphates.
Wińska P; Miazga A; Poznański J; Kulikowski T
Antiviral Res; 2010 Nov; 88(2):176-81. PubMed ID: 20739003
[TBL] [Abstract][Full Text] [Related]
9. Comparative enzymatic study of HIV-1 reverse transcriptase resistant to 2',3'-dideoxynucleotide analogs using the single-nucleotide incorporation assay.
Ueno T; Mitsuya H
Biochemistry; 1997 Feb; 36(5):1092-9. PubMed ID: 9033399
[TBL] [Abstract][Full Text] [Related]
10. Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA.
Peletskaya EN; Kogon AA; Tuske S; Arnold E; Hughes SH
J Virol; 2004 Apr; 78(7):3387-97. PubMed ID: 15016861
[TBL] [Abstract][Full Text] [Related]
11. Investigating the "steric gate" of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by targeted insertion of unnatural amino acids.
Klarmann GJ; Eisenhauer BM; Zhang Y; Gotte M; Pata JD; Chatterjee DK; Hecht SM; Le Grice SF
Biochemistry; 2007 Feb; 46(8):2118-26. PubMed ID: 17274599
[TBL] [Abstract][Full Text] [Related]
12. The sugar ring conformation of 4'-ethynyl-2-fluoro-2'-deoxyadenosine and its recognition by the polymerase active site of HIV reverse transcriptase.
Kirby KA; Singh K; Michailidis E; Marchand B; Kodama EN; Ashida N; Mitsuya H; Parniak MA; Sarafianos SG
Cell Mol Biol (Noisy-le-grand); 2011 Feb; 57(1):40-6. PubMed ID: 21366961
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human immunodeficiency virus reverse transcriptase by synadenol triphosphate and its E-isomer.
Wang R; Harada S; Mitsuya H; Zemlicka J
J Med Chem; 2003 Oct; 46(22):4799-802. PubMed ID: 14561099
[TBL] [Abstract][Full Text] [Related]
14. Probing nonnucleoside inhibitor-induced active-site distortion in HIV-1 reverse transcriptase by transient kinetic analyses.
Xia Q; Radzio J; Anderson KS; Sluis-Cremer N
Protein Sci; 2007 Aug; 16(8):1728-37. PubMed ID: 17656585
[TBL] [Abstract][Full Text] [Related]
15. Conformational properties of nucleotide-based template-competitive HIV-1 reverse transcriptase inhibitors: analysis of enzyme binding modes.
Lin W; Li K; Moore BM; Doughty MB
Nucleosides Nucleotides Nucleic Acids; 2003 Mar; 22(3):283-97. PubMed ID: 12816387
[TBL] [Abstract][Full Text] [Related]
16. Structures of HIV-1 RT-RNA/DNA ternary complexes with dATP and nevirapine reveal conformational flexibility of RNA/DNA: insights into requirements for RNase H cleavage.
Das K; Martinez SE; Bandwar RP; Arnold E
Nucleic Acids Res; 2014 Jul; 42(12):8125-37. PubMed ID: 24880687
[TBL] [Abstract][Full Text] [Related]
17. Effect of a bound non-nucleoside RT inhibitor on the dynamics of wild-type and mutant HIV-1 reverse transcriptase.
Zhou Z; Madrid M; Evanseck JD; Madura JD
J Am Chem Soc; 2005 Dec; 127(49):17253-60. PubMed ID: 16332074
[TBL] [Abstract][Full Text] [Related]
18. Crystal structures of a ddATP-, ddTTP-, ddCTP, and ddGTP- trapped ternary complex of Klentaq1: insights into nucleotide incorporation and selectivity.
Li Y; Waksman G
Protein Sci; 2001 Jun; 10(6):1225-33. PubMed ID: 11369861
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of HIV-1 reverse transcriptase by an antiviral inhibitor, (R)-9-(2-Phosphonylmethoxypropyl)adenine.
Suo Z; Johnson KA
J Biol Chem; 1998 Oct; 273(42):27250-8. PubMed ID: 9765248
[TBL] [Abstract][Full Text] [Related]
20. The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase.
Gao HQ; Boyer PL; Sarafianos SG; Arnold E; Hughes SH
J Mol Biol; 2000 Jul; 300(2):403-18. PubMed ID: 10873473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
